Form 8-K - Current report:
SEC Accession No. 0001062993-17-005167
Filing Date
2017-12-05
Accepted
2017-12-05 11:54:51
Documents
3
Period of Report
2017-12-01
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 8101
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 6516
3 GRAPHIC exhibit99-1x2x1.jpg GRAPHIC 3055
  Complete submission text file 0001062993-17-005167.txt   20273
Mailing Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4
Business Address 156 VALLEYVIEW ROAD KELOWNA A1 V1X 3M4 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: 8-K | Act: 34 | File No.: 000-52138 | Film No.: 171239039
SIC: 1000 Metal Mining